We are live on ! Find out more
VVM

Versant Venture Management Portfolio holdings

AUM $141M
1-Year Est. Return 190.82%
This Fund
S&P 500
This Quarter Est. Return
+10.75%
1 Year Est. Return
+190.82%
3 Year Est. Return
+375.7%
5 Year Est. Return
+81.85%
10 Year Est. Return
+4,735.29%
AUM
$114M
AUM Growth
+$9.11M
Cap. Flow
+$5.01M
Cap. Flow %
4.41%
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
INGN icon
Inogen
INGN
+$5.01M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 85.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLVS
1
DELISTED
Clovis Oncology, Inc.
CLVS
$60.5M 53.2%
814,833
– –
FPRX
2
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$25M 21.95%
1,092,152
– –
AKAO
3
DELISTED
Achaogen Inc
AKAO
$12.5M 11%
1,281,152
– –
CBAY
4
DELISTED
Cymabay Therapeutics
CBAY
$7.26M 6.38%
1,048,601
– –
INGN icon
5
Inogen
INGN
$175M
$4.97M 4.37%
+155,284
New +$5.01M
KYTH
6
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$3.53M 3.1%
70,376
– –

Similar funds

POIA
Pin Oak Investment Advisors Houston, Texas $141M AUM 20.83% 1-Year Est. Return
MAM
Maytree Asset Management Hong Kong $141M AUM 114% 1-Year Est. Return
TM
TFJ Management Somerville, Massachusetts $141M AUM 9.28% 1-Year Est. Return
IA
IF Advisors San Antonio, Texas $141M AUM
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
RB
Renasant Bank Tupelo, Mississippi $141M AUM 16.9% 1-Year Est. Return
YEPX
Yorktown Energy Partners XI New York $142M AUM 130.51% 1-Year Est. Return
CFGW
Chancellor Financial Group WB Wilkes-Barre, Pennsylvania $141M AUM 23.22% 1-Year Est. Return

Versant Venture Management's Q1 2015 Portfolio in Review

As of Q1 2015, Versant Venture Management held 6 positions worth $114M, up 8.7% from $105M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Versant Venture Management deployed $5.01M of net new capital in Q1 2015, opening 1 new position. Its largest new stake was Inogen: 155,284 shares worth $4.97M.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, up from 82% a quarter earlier.

  • Versant Venture Management's largest Q1 2015 buy was Inogen: 155,284 shares worth $4.97M.
  • Versant Venture Management's ten largest holdings make up 100% of its $114M portfolio in Q1 2015.
  • Versant Venture Management opened 1 new position and closed 0 in Q1 2015.
  • Versant Venture Management's portfolio value rose 8.7% quarter-over-quarter to $114M.

Based on Versant Venture Management's 13F filing for Q1 2015, filed 23 Apr 2015.